Skip to main content
. 2022 Oct 19;60(1):247–263. doi: 10.1007/s12035-022-03063-3

Table 3.

Potential inhibitors of DUBs involved in therapeutic implications in neurodegenerative diseases

Disease Compounds Target protein Functional implication of the compound References
PD CMPD-39 USP30 Enhance peroxisome turnover and mitophagy [173]
PD FT3967385 USP30 Accelerate PINK1 generation of phospho-Ser65 ubiquitin [174]
AD IU1 USP14 Accelerate tau degradation [175177]
AD LDN57444 UCHL1 Inhibit tau aggregation and affect APP processing [178180]
ALS HBX41108 USP7 Inhibit the toxicity of the mutant SOD1 in neurons [181]

For each disease, the list is sorted alphabetically by “Compounds”